| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.5 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |